Synlogic, Inc., a Cambridge, Mass.-based biotechnology company focused on the development of therapeutic microbes, raised $29.4m in Series A financing.
The round was led by Atlas Venture and New Enterprise Associates (NEA).
The company plans to use the proceeds to further develop its proprietary microbial engineering platform for the development of therapeutic microbes and advance its preclinical pipeline across several clinical applications.
Co-founded in Fall 2013 by Dr. Mahadevia, Atlas Venture; Jim Collins Ph.D., William Fairfield Warren Distinguished Professor, University Professor, Professor of Biomedical Engineering, and Professor of Medicine at Boston University; and Timothy Lu M.D., Ph.D., Associate Professor of Electrical Engineering and Biological Engineering at the Massachusetts Institute of Technology (MIT), the company was incubated as part of the Atlas Venture seed program. Peter Barrett, Ph.D., Partner at Atlas Venture, Ed Mathers, Partner at NEA, and Dr. Mahadevia will serve on the Synlogic board of directors.
FinSMEs
22/07/2014